Skip to main content
OpenTrials

Clinical trial condition

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Explore clinical trials studying Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) trial results

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

NCT03394365

Conditions
Allogeneic Hematopoietic Cell Transplant, DNA Virus Infections, Epstein-Barr Virus Infections, +12 more
Locations
  • City of Hope (Adults and Pediatrics) Duarte, California, United States
  • University of California San Diego Moores Cancer Center (Adults only) La Jolla, California, United States
  • Loma Linda University Medical Center (Adults only) Loma Linda, California, United States
  • Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) Los Angeles, California, United States
View all 71 locations
View Trial Details

Related conditions